XTalks

APRIL 11, 2024

This could be seen as a positive for companies developing CAR T-cell therapies for autoimmune diseases and solid tumors. J&J’s Carvykti vs. BMS’ Abecma: Continuing Face Off as Market Rivals Carvykti’s expanded second-line approval gives it a one-line edge over Abecma’s third-line nod.

FDA Approval 52

FDA Approval Manufacturing Trials Clinical Trials 52

Pharmaceutical Technology

JUNE 19, 2023

Although only a small number of gene therapies have reached the market thus far, the industry is poised to grow quickly over the next few years. As the clinical trials industry adapts to the rising demand, it must also tackle important challenges concerning the way advanced medicines like cell and gene therapies are handled.

Gene Therapy 130

Gene Therapy Gene Packaging Packaging 130

The Pharma Data

JANUARY 10, 2021

About MorphoSys MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies for patients suffering from cancer and autoimmune diseases. In 2017, Tremfya (R) , developed by Janssen Research & Development, LLC and marketed by Janssen Biotech, Inc.,

Containment 52

Containment Clinical Development Antibody Development 52

XTalks

APRIL 6, 2023

Modern software development concepts from ecommerce applications are helping eClinical applications meet the precise needs of each clinical trial. IRT solutions help clinical trial sponsors meet the complexities of patient randomization and clinical supply management. How is Modern Software Impacting IRT Platforms?

Clinical Trials 98

Clinical Trials Clinical Trials Clinical Supply Trials 98

The Pharma Data

JANUARY 24, 2021

Management of the Company believe that the proposed acquisition will strengthen PharmaDrug’s product pipeline, intellectual property portfolio and pharmaceutical development expertise. Research and development efforts will be led by Dr. Paul Van Slyke. The global esophageal cancer drugs market is estimated to grow by USD $1.5

Drugs 52

Drugs Containment Development Sales 52

Pharmaceutical Technology

APRIL 28, 2023

The company has been ranked in the Business Expansion and Research and Development categories in the Pharmaceutical Technology Excellence Rankings. The company has been ranked in the Business Expansion and Research and Development categories in the Pharmaceutical Technology Excellence Rankings. until 2026. until 2026.

Manufacturing 130

Manufacturing Antibody Clinical Supply Protein 130

The Pharma Data

DECEMBER 4, 2021

company (NASDAQ: AMZN), announced that it is working with Pfizer to create innovative, cloud-based solutions with the potential to improve how new medicines are developed, manufactured, and distributed for testing in clinical trials. (AWS), an Amazon.com, Inc.

Manufacturing 52

Manufacturing Development Drugs Clinical Supply Chain 52

Clinical Trial Podcast

DECEMBER 29, 2022

Sonna is currently the President at NuPulse Inc, an early stage medical device company responsible for developing the first minimally invasive, long-term, ambulatory counterpulsation device that works in sync with the heart. The post Heart Failure Clinical Trials with Sonna Patel-Raman appeared first on Clinical Trial Podcast & Blog.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Supply 52

Drug Discovery World

MARCH 13, 2023

The individual successes within the CGT market are impressive, but this therapeutic class remains unattainable to the vast majority of the world. Before 2019, CGT drug developers still had a young, academic mindset, ordering reagents, materials, and equipment haphazardly and assuming they would show up when needed.

Gene Therapy 52

Gene Therapy Gene Manufacturing Development 52

Client Pharma

DECEMBER 13, 2021

Collaboration provides clinical trial sponsors with access to the world’s most efficient clinical supply processes using a single contract. As a result, global clinical supply and operations teams can now single source their commercial drug requirements by utilizing two best-in-class solution providers.

Clinical Supply 52

Clinical Supply Clinical Trials Clinical Trials Life Science 52

Clinical Trial Podcast

JANUARY 17, 2023

Standalone clinical trial sites enjoy the freedom of running their own operations. But they may face challenges with executing some parts of a clinical trial. His goal is to accelerate the development of new therapies by creating innovative solutions that connect and empower the clinical trial ecosystem.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Supply 52

The Pharma Data

NOVEMBER 18, 2020

Trial to be paused pending analysis of data and evaluation of plans for further development. In addition, travel restrictions could create logistical challenges for the shipment of clinical supplies. The Company aspires to become a leader in the development of targeted therapies for haematological cancers.

Trials 40

Trials Production Development Marketing 40

Pharmaceutical Technology

MARCH 20, 2023

Therefore, the available patient pool of a majority Black population in Africa represents an invaluable opportunity to develop medical products for patients with unmet clinical needs. Therefore, they are open to clinical trials, because of the lack of costs that they have to put towards it. being African American, 3.4%

Clinical Trials 130

Clinical Trials Clinical Trials Trials Clinical Supply Chain 130

Pharmaceutical Technology

MAY 23, 2023

With many clinical trial participants from Ukraine leaving the country after the outbreak of the war, clinical research organisations (CROs) played a crucial role in ensuring trial continuity. Oximio’s team have worked around the clock to ensure continuity in the clinical supply chain in Ukraine. Credit: Oximio.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Clinical Supply Chain 130